Artritis reumatoide en paciente con acromegalia: un reto diagnóstico

Viviana Parra Izquierdo; Francy Cuervo; Miguel Tejada; Sergio Mora

doi:10.47196/rar.v29i1.541

Viviana Parra Izquierdo Palermo Clinic, Bogotá, Colombia
Francy Cuervo University of La Sabana, Bogotá, Colombia
Miguel Tejada San José Hospital, Bogotá, Colombia
Sergio Mora La Samaritana University Hospital, Bogotá, Colombia

DOI: https://doi.org/10.47196/rar.v29i1.541

Keywords: acromegaly, rheumatoid arthritis, arthropathy

Abstract

Acromegaly is a chronic disease characterized by hypersecretion of the growth hormone (GH) and the insulin-like growth factor-I (IGF-I). Frequently the joint is compromised by acromegaly, leading to significant morbidity and functional impairment, given that the GH directly generates bone changes and cartilage damage. The relation of acromegaly with rheumatoid arthritis is rare, making it a real challenge for the physician´s early diagnosis and aggressive medical intervention in order to avoid irreversible effects common in rheumatoid arthritis. We report the case of a patient in the fifth decade of life with an evolution of 10 years of acromegaly, as a result of a pituitary adenoma, producer of the GH and early rheumatoid arthritis diagnose.

Author Biographies

Viviana Parra Izquierdo, Palermo Clinic, Bogotá, Colombia

Internist Physician. Rheumatologist. Gastroenterologist

Francy Cuervo, University of La Sabana, Bogotá, Colombia

Internist Physician

Miguel Tejada, San José Hospital, Bogotá, Colombia

Internist Physician. Cardiologist

Sergio Mora, La Samaritana University Hospital, Bogotá, Colombia

Internist Physician. Rheumatologist

References

I. Chanson P, Salenave S, Kamenicky P, Cazabat L, Young J. Pituitary tumours: acromegaly. Best Pract Res Clin Endocrinol Metab. 2009;23(5):555-74.

II. Colao A, Marzullo P, Vallone G, Marino V, Annecchino M, Ferone D, et al. Reversibility of joint thickening in acromegalic patients: an ultrasonography study. J Clin Endocrinol Metab. 1998;83(6):2121-5.

III. Bluestone R, Bywaters EG, Hartog M, Holt PJ, Hyde S. Acromegalic arthropathy. Ann Rheum Dis. 1971;30(3):243-58.

IV. Melmed S. Medical progress: Acromegaly. N Engl J Med. 2006;355(24):2558-73.

V. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev. 2004;25(1):102-52.

VI. Clayton RN. Cardiovascular function in acromegaly. Endocr Rev. 2003;24(3):272-7.

VII. Orme SM, McNally RJ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab. 1998;83(8):2730-4.

VIII. Barkan AL. Acromegalic arthropathy. Pituitary. 2001;4(4):263-4.

IX. Barkan A. Acromegalic arthropathy and sleep apnea. J Endocrinol. 1997;155 Suppl 1:S41-4; discussion S5.

X. Dons RF, Rosselet P, Pastakia B, Doppman J, Gorden P. Arthropathy in acromegalic patients before and after treatment: a long-term follow-up study. Clin Endocrinol (Oxf). 1988;28(5):515-24.

XI. Killinger Z, Payer J, Lazurova I, Imrich R, Homerova Z, Kuzma M, et al. Arthropathy in acromegaly. Rheum Dis Clin North Am. 2010;36(4):713-20.

XII. Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F. Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab. 2005;90(5):2731-9.

XIII. Scarpa R, De Brasi D, Pivonello R, Marzullo P, Manguso F, Sodano A, et al. Acromegalic axial arthropathy: a clinical case-control study. J Clin Endocrinol Metab. 2004;89(2):598-603.

XIV. D etenbeck LC, Tressler HA, O'Duffy JD, Randall RV. Peripheral joint manifestations of acromegaly. Clin Orthop Relat Res. 1973(91):119-27.

XV. Colao A, Pivonello R, Scarpa R, Vallone G, Ruosi C, Lombardi G. The acromegalic arthropathy. J Endocrinol Invest. 2005;28(8 Suppl):24-31.

XVI. Jenkins PJ, Sohaib SA, Akker S, Phillips RR, Spillane K, Wass JA, et al. The pathology of median neuropathy in acromegaly. Ann Intern Med. 2000;133(3):197-201.

XVII. Lesse GP, Fraser WD, Farquharson R, Hipkin L, Vora JP. Gonadal status is an important determinant of bone density in acromegaly. Clin Endocrinol (Oxf). 1998;48(1):59-65.

XVIII. Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A, et al. Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab. 2008;93(12):4649-55.

XIX. Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev. 2008;29(5):535-59.

XX. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137-48.

XXI. Ozcakar L, Akinci A, Bal S. A challenging case of rheumatoid arthritis in an acromegalic patient. Rheumatol Int. 2003;23(3):146-8.

XXII. Aydin Y, Coskun H, Kir S, Yazici S, Kudas O, Gungor A. Rheumatoid arthritis masquerading as acromegaly recurrence: report of two cases. Rheumatol Int. 2012;32(9):2913-5.

XXIII. Read RC, Watt I, Dieppe PA. Rheumatoid arthritis and acromegaly--effect of growth factors on RA? Br J Rheumatol. 1988;27(3):242-3.

XXIV. Miyoshi T, Otsuka F, Kawabata T, Inagaki K, Mukai T, Kawashima M, et al. Manifestation of rheumatoid arthritis after transsphenoidal surgery in a patient with acromegaly. Endocr J. 2006;53(5):621-5.

XXV. Podgorski M, Robinson B, Weissberger A, Stiel J, Wang S, Brooks PM. Articular manifestations of acromegaly. Aust N Z J Med. 1988;18(1):28-35.

XXVI. Oruk G, Tarhan F, Argin M, Ozmen M. Is every joint symptom related to acromegaly? Endocrine. 2013;43(2):404-11.

Rheumatoid arthritis in a patient with acromegaly: a diagnostic challenge

Abstract

Author Biographies

References

Argentine Journal of Rheumatology